Fund Name: Commercialising quantum devices: innovation R&D
Project Length: Up to 29 months
Project Value: Share of £20M
Commercialising quantum devices: innovation R&D. The aim of this competition is to advance the commercialisation of quantum technologies in the UK. Innovate UK will invest £20 million in innovation projects to develop prototype quantum technology devices that address one or more important industrial challenges.
Fund Name: Biomedical Catalyst
Project Length: 6 - 36 Months
Project Value: Up to £8M
Small or medium-sized UK companies can apply for a share of up to £8 million to work alone or with others on solving healthcare challenges – either in a model system (primer award) or in a clinical setting or a relevant late stage environment (late stage award).
Fund Name: Agri-tech Catalyst Colombia
Project Length: Up to 18 months
Project Value: Share of £3M
Agri-tech Catalyst Colombia. Innovate UK, through the Colombian Prosperity Fund Programme, will invest up to £3 million. This is to enable UK and Colombian partners to address agricultural challenges in post-conflict and conflict-affected regions in Colombia.
Fund Name: Building the Next Generation of Global Citizens for the Global Goals
Project Length: No more than 12 months
Project Value: Up to $100,000
Global Grand Challenges are seeking innovators to devise and demonstrate ways to positively engage young people (under the age of 30) in Global Citizenship at scale and in depth.
Fund Name: Medicines Manufacturing Strand 2
Project Length: 12 and 30 months
Project Value: Share of £10M
This competition aims to stimulate the development of innovative methods or technologies to improve the manufacture of novel medicines for human use. ‘Novel’ medicines are those that have not yet been commercially launched on the market but may have been applied as part of clinical trials or under exemptions from the UK Human Medicines Regulations.
Fund Name: Health and Life Sciences Fund
Project Length: No longer than 12 months
Project Value: Share of 19M
Innovate UK Health & Life sciences. This flagship fund is more than likely to come around again- keep looking.